News summaryTMTPostNov 8, 2026, 12:13 PM
OpenAI and Peers Expand Their AI Drug-Discovery Efforts
aiartificial_intelligencepharmaceuticals
OpenAI released its life-sciences model GPT-Rosalind in April, describing it as a tool to accelerate drug discovery. [[fact-adkgrdv47]] Anthropic acquired AI biotechnology startup Coefficient Bio for $400 million. [[fact-62bd9jlrs]] Isomorphic Labs completed a $2.1 billion Series B, while Anew Labs raised $290 million in its first funding round at a post-money valuation of about $1.5 billion. [[fact-ri5arjf37]][[fact-fs9sk0vgb]] Huawei’s pharmaceutical division president, Fan Jie, said Huawei does not develop drugs or drug pipelines and instead positions itself as an AI enabler for the pharmaceutical industry. [[fact-ryl85om7x]]